GlucoTrack, Inc.
GCTK Healthcare Medical Instruments & Supplies
In the quarter to June 2026, EPS grew 92.1%, free cash flow grew 3.42% and total debt rose 777.8%, each against the same quarter a year earlier.
Follow GCTK
GlucoTrack, Inc. (GCTK) Altman Z-score
GlucoTrack, Inc.'s Altman Z-score for fiscal 2019 is 26019048.63, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2019 | 26019048.63 | 25,191,704.58 |
| FY2018 | 827344.05 | 343,729.92 |
| FY2017 | 483614.12 | (273,956.33) |
| FY2016 | 757570.46 | (720,608.45) |
| FY2015 | 1478178.91 | — |
How fiscal 2019’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | (1.42) | — | −1.70 | |
| Retained earnings / total assets | (82.76) | — | −115.86 | |
| EBIT / total assets | (3.20) | — | −10.56 | |
| Market value of equity / total liabilities | 43,365,294.26 | — | 26019176.56 | |
| Sales / total assets | 0.19 | — | 0.19 | |
| Altman Z-score | Safe zone | 26019048.63 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Distress zone | −301.18 | ||
Z and Z″ put GlucoTrack, Inc. in different zones: safe zone by Z, distress zone by Z″.
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| GCTK GlucoTrack, Inc. | 26,019,049× |
| NXGL NexGel, Inc. compare | 24.6× |
| MHUAF Meihua International Medical Technologies Co., Ltd. compare | 2.0× |
| RVP Retractable Technologies, Inc. compare | 0.6× |
| CUPR Cuprina Holdings (Cayman) Limited compare | −1.0× |
| LUCY Innovative Eyewear, Inc. compare | −3.7× |
| FEMY Femasys Inc. compare | −10.9× |
| BNGO Bionano Genomics, Inc. compare | −14.3× |
| RGNT Regentis Biomaterials Ltd. compare | — |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets